Jason Aryeh, Director of Orchestra BioMed Holdings OBIO, has filed 3 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $1.2M. The latest trade was on 06/23.

JA

JA

Jason Aryeh

Director

Company

Orchestra BioMed Holdings OBIO

First filing

23/01/30

Trades

46 trades

Buys / sales

3 / 5

12-month net buying

−$1.2M

Last trade

06/23

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Ligand PharmaceuticalsLGND	Open-market sale	06/10–06/11	06/12	5,000 sh2 trades	$250.00avg.	$1,250,000	−4.6%
Orchestra BioMed HoldingsOBIO	Open-market buy	05/18	05/20	665 sh	$3.75	$2,493.75	+0.6%
Orchestra BioMed HoldingsOBIO	Open-market buy	05/15	05/19	8,971 sh	$3.90	$34,986.9	+8.3%
Ligand PharmaceuticalsLGND	Open-market sale	25/09/23	25/09/24	10,000 sh3 trades	$170.81avg.	$1,708,085.94	−12.6%
Orchestra BioMed HoldingsOBIO	Open-market buy	25/09/19	25/09/19	1,000 sh	$2.45	$2,450	+0.9%